Gilder Gagnon Howe & Co’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.48M | Buy |
123,127
+106,239
| +629% | +$3.86M | 0.05% | 150 |
|
|
2025
Q1 | $612K | Sell |
16,888
-40
| -0.2% | -$1.45K | 0.01% | 204 |
|
|
2024
Q4 | $712K | Sell |
16,928
-2,661
| -14% | -$112K | 0.01% | 225 |
|
|
2024
Q3 | $1.09M | Sell |
19,589
-338
| -2% | -$18.8K | 0.01% | 206 |
|
|
2024
Q2 | $819K | Buy |
19,927
+2,504
| +14% | +$103K | 0.01% | 213 |
|
|
2024
Q1 | $813K | Sell |
17,423
-177
| -1% | -$8.26K | 0.01% | 219 |
|
|
2023
Q4 | $842K | Buy |
17,600
+8,008
| +83% | +$383K | 0.01% | 211 |
|
|
2023
Q3 | $342K | Sell |
9,592
-56
| -0.6% | -$2K | 0.01% | 238 |
|
|
2023
Q2 | $445K | Buy |
+9,648
| New | +$445K | 0.01% | 251 |
|
|
2022
Q3 | – | Sell |
-5,048
| Closed | -$301K | – | 254 |
|
|
2022
Q2 | $301K | Sell |
5,048
-1,703
| -25% | -$102K | 0.01% | 239 |
|
|
2022
Q1 | $490K | Sell |
6,751
-7,283
| -52% | -$529K | ﹤0.01% | 267 |
|
|
2021
Q4 | $1.18M | Sell |
14,034
-4,026
| -22% | -$339K | 0.01% | 289 |
|
|
2021
Q3 | $1.63M | Sell |
18,060
-284
| -2% | -$25.6K | 0.01% | 308 |
|
|
2021
Q2 | $1.75M | Sell |
18,344
-44
| -0.2% | -$4.2K | 0.01% | 308 |
|
|
2021
Q1 | $2.09M | Sell |
18,388
-4,896
| -21% | -$558K | 0.01% | 277 |
|
|
2020
Q4 | $3.22M | Buy |
+23,284
| New | +$3.22M | 0.02% | 232 |
|
|
2016
Q4 | – | Sell |
-6,840
| Closed | -$485K | – | 283 |
|
|
2016
Q3 | $485K | Sell |
6,840
-2
| -0% | -$142 | 0.01% | 207 |
|
|
2016
Q2 | $335K | Sell |
6,842
-13
| -0.2% | -$637 | 0.01% | 216 |
|
|
2016
Q1 | $434K | Buy |
+6,855
| New | +$434K | 0.01% | 182 |
|
|
2015
Q3 | – | Sell |
-4,235
| Closed | -$434K | – | 278 |
|
|
2015
Q2 | $434K | Sell |
4,235
-2,927
| -41% | -$300K | 0.01% | 233 |
|
|
2015
Q1 | $445K | Sell |
7,162
-162
| -2% | -$10.1K | 0.01% | 225 |
|
|
2014
Q4 | $321K | Sell |
7,324
-243
| -3% | -$10.7K | ﹤0.01% | 234 |
|
|
2014
Q3 | $428K | Sell |
7,567
-22
| -0.3% | -$1.24K | 0.01% | 235 |
|
|
2014
Q2 | $341K | Sell |
7,589
-12,702
| -63% | -$571K | ﹤0.01% | 252 |
|
|
2014
Q1 | $992K | Buy |
+20,291
| New | +$992K | 0.01% | 212 |
|